Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 2Completed 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 1Endocrine 1

Conditions

Breast Neoplasms 214Neoplasms 197Carcinoma, Non-Small-Cell Lung 91Colorectal Neoplasms 89Prostatic Neoplasms 78Lung Neoplasms 75Multiple Myeloma 49Head and Neck Neoplasms 47Melanoma 46Pancreatic Neoplasms 45Neoplasm Metastasis 44Leukemia, Myeloid, Acute 41Carcinoma, Hepatocellular 41Recurrence 37Brain Neoplasms 37Squamous Cell Carcinoma of Head and Neck 34Ovarian Neoplasms 32Glioblastoma 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Glioma 29Uterine Cervical Neoplasms 27Sarcoma 27Stomach Neoplasms 26Lymphoma, Non-Hodgkin 26Lymphoma 26Carcinoma, Renal Cell 26Motor Activity 24Lymphoma, Follicular 24Colonic Neoplasms 23Lymphoma, Large B-Cell, Diffuse 22

Interventions

Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Osteoporosis × 90 days × Clear all
NCT05927623 2026-04-20

MisterFIt

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Completed
45 enrolled
Endocrine

Muscular Atrophy, Osteoporosis, Multiple Endocrine Neoplasia Type 1, Osteoporotic Fractures

NCT03401060 2026-03-31

DenosuMast

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
24 enrolled
Myeloid

Osteoporosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡